Importance of checking anti-glomerular basement membrane antibody status in patients with antineutrophil cytoplasmic antibody-positive vasculitis

被引:5
作者
Gallagher, J. L. [1 ]
Sinha, S. [1 ]
Reeve, R. [1 ]
Kalra, P. A. [1 ]
机构
[1] Hope Hosp, Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England
关键词
D O I
10.1136/pgmj.2007.062752
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The case is reported of a 68-year-old man with perinuclear anti-neutrophil cytoplasmic antibody ( pANCA)associated glomerulonephritis who developed antibodies to glomerular basement membrane ( anti-GBM) resulting in end stage renal failure. His pANCA titre on admission was 1: 1024 IgG and he was anti-myeloperoxidase positive. A renal biopsy showed advanced sclerosing necrotising glomerulonephritis consistent with a pauciimmune ANCA-positive glomerulonephritis. He was treated with steroids and cyclophosphamide. His serum creatinine profile improved. He had a relapse of disease 16 months later, which was successfully treated. After a further 16 months, he presented with acute renal failure ( creatinine 1060 mu mol/l). His pANCA titre on admission was 1: 64 IgG. This was treated as a further relapse of ANCA-positive vasculitis. He became oliguric and his haemoglobin concentration fell. Eight days after admission, he was found to be strongly positive for anti-GBM ( 138 U/ml). Despite receiving cyclophosphamide, steroids and plasma exchange, he remained dialysis-dependent.
引用
收藏
页码:220 / 222
页数:3
相关论文
共 11 条
[1]  
Heeringa P, 1996, AM J PATHOL, V149, P1695
[2]   WEGENER GRANULOMATOSIS - AN ANALYSIS OF 158 PATIENTS [J].
HOFFMAN, GS ;
KERR, GS ;
LEAVITT, RY ;
HALLAHAN, CW ;
LEBOVICS, RS ;
TRAVIS, WD ;
ROTTEM, M ;
FAUCI, AS .
ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) :488-498
[3]   The increase of antiglomerular basement membrane antibody following pauci-immune-type crescentic glomerulonephritis [J].
Kitagawa W. ;
Miura N. ;
Yamada H. ;
Nishikawa K. ;
Futenma A. ;
Imai H. .
Clinical and Experimental Nephrology, 2005, 9 (1) :69-73
[4]   Clinical features and outcome of patients with both ANCA and anti-GBM antibodies [J].
Levy, JB ;
Hammad, T ;
Coulthart, A ;
Dougan, T ;
Pusey, CD .
KIDNEY INTERNATIONAL, 2004, 66 (04) :1535-1540
[5]   Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression [J].
Levy, JB ;
Turner, AN ;
Rees, AJ ;
Pusey, CD .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (11) :1033-1042
[6]  
Little MA, 2004, J NEPHROL, V17, pS10
[7]   Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis [J].
Rutgers, A ;
Slot, M ;
van Paassen, P ;
Vriesman, PV ;
Heeringa, P ;
Tervaert, JWC .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (02) :253-262
[8]  
Rutgers A, 2003, Eur J Intern Med, V14, P287, DOI 10.1016/S0953-6205(03)00097-9
[9]   Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis [J].
Serratrice, J ;
Chiche, L ;
Dussol, B ;
Granel, B ;
Daniel, L ;
Jego-Desplat, S ;
Disdier, P ;
Swiader, L ;
Berland, Y ;
Weiller, PJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (03)
[10]   Sequential development of anti-GBM nephritis and ANCA-associated pauci-immune glomerulonephritis [J].
Verburgh, CA ;
Bruijn, JA ;
Daha, MR ;
van Es, LA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (02) :344-348